Improved gene therapy analytics permit monitoring of critical quality attributes and increased manufacturing efficiency



Jonathan Royce, Director, Instruments Business Unit, Vironova talks about analytics in gene therapy manufacturing. Specifically, Jonathan details new technologies to monitor critical quality attributes, reduce development time and increase the number of projects that can be run.


Leave a Reply

*